Sandoval Elisabeth 4
4 · Satsuma Pharmaceuticals, Inc. · Filed Jun 7, 2022
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-03+30,000→ 30,000 totalExercise: $3.46Exp: 2032-06-02→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option shall vest in full and become exercisable on the day immediately preceding the 2023 Annual Meeting.